Privacy Policy

Pharmacyclics, Inc. respects the privacy of visitors to its web site. This Privacy Policy describes the personal information that we collect, how we use that information, and what we do to protect that information. By accessing this site and submitting information to us, you agree to be bound by the terms of this policy.

We will only collect personal information such as your name, e-mail address, mailing address or telephone number when it is voluntarily submitted through the web site. We use this information to provide you with information you have requested about our company. We may share your information with our agents or contractors in connection with services that these agents or contractors perform for us.

This site may also collect non-personal information, including information about your browser and operating system software, pages visited, and other navigational data. This information is used to improve accessibility of the site.

This web site is not intended or designed for use by children under the age of 13. We do not intentionally collect personal information from children under 13.

As a convenience to users, this web site may contain links to other sites. Provision of such links does not imply Pharmacyclics’ endorsement of the content of these sites. Pharmacyclics has no control over the contents of external sites and this Privacy Policy does not apply to such sites.

We reserve the right to amend this Privacy Policy at any time. Any changes will be posted on the site at this location. If you have any questions concerning this Privacy Policy, please contact us at info@pcyc.com.

The information provided herein may contain references to ibrutinib or a use of ibrutinib which has not been approved by any regulatory agency. Providing this information should not be construed as recommending the use of ibrutinib for uses which may not have been approved by any regulatory agency. The safety and efficacy of the investigational use of ibrutinib has not been determined. There is no guarantee that the investigational uses listed will be filed with and/or approved for marketing by any regulatory agency. For additional information, you may visit www.clinicaltrials.gov. For products approved by any regulatory agency please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product for its approved indications.